HCPLive

Infectious Agents Cause About One in Six Cancers Worldwide

Wednesday, May 9 (HealthDay News) -- Catherine de Martel, M.D., from the International Agency for Research on Cancer in Lyon, France, and colleagues utilized statistics on estimated cancer incidence in 2008 to calculate the population attributable fraction (PAF) of infectious agents classified as carcinogenic to humans, worldwide and in eight geographic regions. Calculations were based on the prevalence of infection in cancer cases rather than in the general population, when the associations were very strong.

The researchers found that, of the 12.7 million new cancer cases that occurred in 2008, the PAF for infectious agents was 16.1 percent. This represented about two million new cases. The fraction of infection-attributable cancers was higher in less developed countries than in more developed countries (22.9 versus 7.4 percent). Approximately 1.9 million cases of gastric, liver, and cervix uteri cancers were caused by Helicobacter pylori, hepatitis B and C viruses, and human papillomaviruses. Cervix uteri cancer accounted for about half of the infection-related burden of cancer in women, while liver and gastric cancers accounted for more than 80 percent in men. Younger people (<50 years) were affected by approximately 30 percent of infection-attributable cases.

"Around two million cancer cases each year are caused by infectious agents," the authors write. "Application of existing public health methods for infection prevention, such as vaccination, safer injection practice, or antimicrobial treatments, could have a substantial effect on the future burden of cancer worldwide."

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Globally, nearly two million new cancer cases are caused by infectious agents each year, according to a study published online May 9 in The Lancet Oncology.


Copyright © 2012 HealthDay. All rights reserved.

Most Popular

Recommended Reading

Researchers foresee new, effective Ebola treatments in the future due to a promising discovery in the deadly disease’s replication process.
Young leukemia patients are at risk for peripheral neuropathy due to an inherited gene variation, according to research published in JAMA.
Too few women at high risk for osteoporosis are being tested for the condition, while too many women at low risk are being screened, according to new research published online May 19 in the Journal of General Internal Medicine.

Higher altitude may up the risk of sudden infant death syndrome (SIDS), according to a new study published online May 25 in Pediatrics.

$vAR$